Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2014
03/12/2014CN102065881B Stable amyloid BETA monomers and oligomers
03/12/2014CN101998965B Immunosuppressive polypeptides and nucleic acid
03/12/2014CN101884784B Bv8 nucleic acids and polypeptides with mitogenic activity
03/12/2014CN101663043B Methods and compositions for fostering and preserving bone growth
03/12/2014CN101641114B Treatment of inflammation and/or endotoxic shock
03/12/2014CN101605806B Crystalline D-isoglutamyl-D-tryptophan and mono ammonium salt of D-isoglutamyl- D-tryptophan
03/12/2014CN101541960B Partial fragment of REIC/Dkk-3 gene and therapeutic agent for cancer containing same
03/12/2014CN101501063B Polymyxin derivatives and uses thereof
03/12/2014CN101466390B Pharmaceutical composition with synergistic anticonvulsant effect
03/12/2014CN101415406B Calcium phosphate complex in acid containing chewing gum
03/12/2014CN101261277B Promyostatin peptides and methods of using same
03/11/2014US8670988 Audio encoding/decoding apparatus and method providing multiple coding scheme interoperability
03/11/2014US8669348 Anti diabetic protein
03/11/2014US8669346 Bone marrow targeting peptides
03/11/2014US8669345 Nogo receptor antagonists
03/11/2014US8669293 Method and compositions for preventing hormone induced adverse effects
03/11/2014US8669237 Biodegradable immunomodulatory formulations and methods for use thereof
03/11/2014US8669231 Activation of peptide prodrugs by hK2
03/11/2014US8669229 Benzazepine derivatives useful as vasopressin antagonists
03/11/2014US8669228 Glucagon analogs exhibiting enhanced solubility in physiological pH buffers
03/11/2014US8669227 Fast-acting insulin formulation
03/11/2014US8669226 Antimicrobial compositions and methods of use thereof
03/11/2014US8669100 DNA expression constructs encoding the Leishmania infantum antigens thiol-specific antioxidant protein and kinetoplastid membrane protein
03/11/2014US8669092 Urocortin-III and uses thereof
03/11/2014US8668927 Dynamin mediated diseases and associated methods and products
03/11/2014US8668907 Highly functional enzyme having α-galactosidase activity
03/11/2014US8668904 Influenza composition
03/11/2014US8668898 Low radiocarbon dietary supplements and foods and methods of making and using same
03/11/2014CA2599150C Anticancer agent comprising paclitaxel and a diptheria toxin mutant, crm 197
03/11/2014CA2581769C Methods of using chimeric coiled-coil molecule
03/11/2014CA2562552C Hybrid recombinases for genome manipulation
03/11/2014CA2558829C Methods for treating viral infection using il-28 and il-29 cysteine mutants
03/11/2014CA2488346C Methods and compositions for the repair and/or regeneration of damaged myocardium
03/11/2014CA2486127C Method of treating dyslipidemic disorders
03/11/2014CA2459862C Oxyntomodulin for preventing or treating excess weight
03/11/2014CA2422429C A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
03/11/2014CA2396428C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
03/11/2014CA2375912C Immunotherapy of autoimmune disorders using antibodies which target b-cells
03/06/2014WO2014036564A1 Oral care composition for promoting and maintaining oral health and method of forming and using same
03/06/2014WO2014036528A2 Agents useful for treating obesity, diabetes and related disorders
03/06/2014WO2014036393A1 A method to improve pharmacokinetics of drugs
03/06/2014WO2014036384A1 Use of il-20 antagonists for promoting bone fracture healing
03/06/2014WO2014036323A1 Method and composition for treating hyperglycemia
03/06/2014WO2014036198A1 Compositions and methods for specific inhibition of leishmania receptor for activated c-kinase (lack)
03/06/2014WO2014035876A1 Heat-inactivated complement factor b compositions and methods
03/06/2014WO2014035828A2 Inhibition of axl signaling in anti-metastatic therapy
03/06/2014WO2014035474A1 Compositions and methods for treating cancer
03/06/2014WO2014035361A1 IL-1β INHIBITOR COMPOSITION AND USE THEREOF
03/06/2014WO2014035345A1 Peptides and uses thereof
03/06/2014WO2014035297A1 Method and agent for the treatment and prophylaxis of diseases caused by (+)rna-containing viruses
03/06/2014WO2014035289A1 A pharmaceutical composition for stimulation of angiogenesis
03/06/2014WO2014034922A1 Peptide for inhibiting vascular endothelial growth factor receptor
03/06/2014WO2014034754A1 Psf1-derived peptide
03/06/2014WO2014034609A1 P53 family chimeric molecule and use thereof
03/06/2014WO2014033441A1 Fusion proteins and methods for treating, preventing or ameliorating pain
03/06/2014WO2014033193A1 Stabilised proteins for immunising against staphylococcus aureus
03/06/2014WO2014033192A1 Stabilised proteins for immunising against staphylococcus aureus
03/06/2014WO2014033184A1 Use of a vegf antagonist in treating ocular vascular proliferative diseases
03/06/2014WO2014032782A1 Jagaricin derivatives and their use as fungicide or antitumor agent
03/06/2014WO2014032176A1 Methods for the treatment of hepatitis b and hepatitis d infections
03/06/2014WO2014032099A1 Composition and method for bone growth
03/06/2014WO2014012025A3 Igf-1 proteins and therapeutic uses thereof
03/06/2014WO2014011819A3 Factor viii complex with xten and von willebrand factor protein, and uses thereof
03/06/2014WO2014009589A3 Use of nuclear localization signals of bacteriophage proteins as gene transfer vehicle
03/06/2014WO2013182984A3 Glycosylated peptides
03/06/2014WO2013170086A3 Formulations for the delivery of active ingredients
03/06/2014WO2013151767A8 Therapy for kidney disease and/or heart failure by intradermal infusion
03/06/2014WO2013116482A9 Process of afod and afcc and manufacturing and purification processes of proteins
03/06/2014WO2013088368A3 Use of the mmp-12 protein in the prevention and/or treatment of aged or senescent skin
03/06/2014WO2012166158A8 Methods and compositions for the treatment of metabolic syndrome, obstructive respiratory disorders, cancer and related diseases
03/06/2014WO2012141764A3 Pre-operative use of metabolic activation therapy
03/06/2014US20140066386 Therapies for hematologic malignancies
03/06/2014US20140066385 Method for treating cancer by combined use of drugs
03/06/2014US20140066383 Methods of treating cancer
03/06/2014US20140066377 Modulating Aquaporins with Relaxin
03/06/2014US20140066376 Protecting and repairing cartilage and musculoskeletal soft tissues
03/06/2014US20140066374 Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity
03/06/2014US20140066373 Treating diabetes with oxytocin or oxytocin analogs
03/06/2014US20140066372 Glucokinase Activator Compositions for the Treatment of Diabetes
03/06/2014US20140066371 Methods for administering long-lasting hypoglycemic agents
03/06/2014US20140066368 Methods For Affecting Body Composition
03/06/2014US20140066367 Subcutaneous delivery of a long-acting natriuretic peptide
03/06/2014US20140066366 Use Of Histones For The Early Diagnosis And/Or Preventive Therapy Of Virally-Infected Living Cells
03/06/2014US20140066365 Use of calixarenes associated with an antibiotic in the treatment of bacterial infections
03/06/2014US20140066364 Cyanoacrylate tissue adhesives
03/06/2014US20140066363 Carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide
03/06/2014US20140066362 Method for treating infections by targeting microbial h2s-producing enzymes
03/06/2014US20140066361 Peptides and use thereof in the inhibition of angiotensin converting enzyme
03/06/2014US20140066360 Methods for using semaphorin polypeptides
03/06/2014US20140066359 Methods for recovering peptides/amino acids and oil/fat from one or more ...
03/06/2014US20140065246 Intracellular calcium modulation for cancer treatment
03/06/2014US20140065245 Method for preparing dietary supplements
03/06/2014US20140065241 Uses of (-)-perhexiline
03/06/2014US20140065232 Controlled release pharmaceutical compositions for acid-labile drugs
03/06/2014US20140065193 Zscan4 as a marker for pancreatic stem cells and progenitor cells and use thereof
03/06/2014US20140065176 T-cell death-inducing epitopes
03/06/2014US20140065168 Anti-kit antibodies and uses thereof
03/06/2014US20140065167 HUMAN IgM ANTIBODIES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF PARTICULARLY IN THE CENTRAL NERVOUS SYSTEM
03/06/2014US20140065161 Treatment method for microbial infection
03/06/2014US20140065148 Treatment methods using antibodies to aminophospholipids
1 ... 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 ... 3163